Serotonin Receptor agonist and Risk of Paresthesia in Migraine Patients: A Dose-Response Model-Based (Network) Meta-Analysis

BACKGROUND: Migraine may be an important factor for paresthesia in the limbs, especially in the upper limbs. In several patients, paresthesia is responsible for a low quality of life. Treatment with the serotonin agonist may be a triggering factor for paresthesia in certain patients. Various seroton...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasan Abdi, Sayed Aliul, Sayed, Shabihul Fatma, Bhaskar, Jamuna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540947/
https://www.ncbi.nlm.nih.gov/pubmed/36211148
http://dx.doi.org/10.4103/aian.aian_972_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540947/
https://www.ncbi.nlm.nih.gov/pubmed/36211148
http://dx.doi.org/10.4103/aian.aian_972_21

Ejemplares similares